Assessment of oral anticoagulation control at two pharmacist-managed clinics in Brazil
- 20 September 2017
- journal article
- research article
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 39 (6) , 1157-1161
Abstract
Background Warfarin remains widely used by patients with cardiovascular diseases. When using warfarin, the quality of oral anticoagulation control is a critical determinant to minimize the risk of bleeding and thromboembolic events. Pharmacist engagement in patient care is relevant towards improving the quality of warfarin therapy. Objective To assess the quality of oral anticoagulation control measured by time in therapeutic range (TTR) at two pharmacist-managed anticoagulation clinics (AC). Method This study included adults with indication of continuous warfarin use. Patients were recruited at two AC of public hospitals in Brazil (2014–2015). Anticoagulation control was assessed by TTR using the Rosendaal method. Laboratory INR values were collected for the maximum period of follow-up (2009–2015). Results A total of 554 patients were studied. The median age was 63.7 [Quartile 1 (Q1) 54.3; Quartile 3 (Q3) 73.6] years, 57.4% female. The median TTR was 64.3% [Q1 54.0%; Q3 74.0%], and 344 (61.6%) patients had TTR ≥ 60%. Conclusion Pharmacist-managed AC have achieved an adequate TTR in Brazilian patients with low socioeconomic status. Interventions include face-to-face appointments for individual patient education, warfarin-dosing adjustments and monitoring of drug interactions. Pharmacists are important to improve adherence and the quality of warfarin therapy in low- and middle income countries.Keywords
This publication has 10 references indexed in Scilit:
- Improvement of time in therapeutic range with warfarin by pharmaceutical interventionInternational Journal of Clinical Pharmacy, 2016
- 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTSEuropean Heart Journal, 2016
- Modelling the cost-effectiveness of pharmacist-managed anticoagulation service for older adults with atrial fibrillation in SingaporeInternational Journal of Clinical Pharmacy, 2016
- Definition of clinically relevant non‐major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non‐surgical patients: communication from the SSC of the ISTHJournal of Thrombosis and Haemostasis, 2015
- National Assessment of Warfarin Anticoagulation Therapy for Stroke Prevention in Atrial FibrillationCirculation, 2014
- Comparing effectiveness of two anticoagulation management models in a Malaysian tertiary hospitalInternational Journal of Clinical Pharmacy, 2013
- Performance outcomes of a pharmacist‐managed anticoagulation clinic in the rural, resource‐constrained setting of Eldoret, KenyaJournal of Thrombosis and Haemostasis, 2011
- Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic RangeCirculation, 2008
- Effect of Study Setting on Anticoagulation ControlChest, 2006
- A Method to Determine the Optimal Intensity of Oral Anticoagulant TherapyThrombosis and Haemostasis, 1993